Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A Randomized, Triple-Blind, Placebo-Controlled Trial of Prophylactic Oral Phenobarbital to Reduce the Need for Phototherapy in G6PD-Deficient Neonates

Journal of Perinatology volume 25, pages 325–330 (2005)Cite this article

Abstract

OBJECTIVE:

Decreased conjugation is probably more important than hemolysis for causing jaundice in G6PD-deficient neonates. The role of enzyme inducers, like phenobarbital, in G6PD deficiency is unclear. This randomized controlled trial was performed to evaluate Phenobarbital's role in reducing the need for phototherapy among G6PD-deficient neonates.

STUDY DESIGN:

This stratified, randomized, triple-blinded, placebo-controlled trial was conducted in a level III NICU. Consecutive babies with gestation ≥34 weeks and birth weight ≥1800 g were screened from cord blood. G6PD-deficient neonates, who were otherwise healthy, were enrolled. Rh isoimmunization, maternal Phenobarbital use and lack of parental consent were exclusion criteria. Subjects were randomly allocated to receive 5 mg/kg day of oral phenobarbital/ placebo for first 3 days. They were monitored daily for total serum bilirubin (TSB) until declining TSB was documented twice. The primary outcome was requirement for phototherapy and secondary outcomes were duration of phototherapy, need for exchange transfusion, peak TSB and adverse effects. Sample size of 56 could detect a decline in phototherapy requirement from 40 to 5% with 80% power and 5% error.

RESULTS:

Of 2370 babies screened, 63 were G6PD-deficient. Of them, 56 eligible babies were allocated to phenobarbital (n=27) or placebo (n=29). The mean age of administration of the first dose was 18.55±7.3 h. In total, 44% in phenobarbital group and 41% in placebo group required phototherapy (p=1.0). There was no significant difference in exchange transfusion rates (18.5 vs 10%, p=0.46). No baby had adverse reactions.

CONCLUSION:

Prophylactic oral phenobarbital does not decrease the need for phototherapy or exchange transfusions in G6PD-deficient neonates.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Jolly JG, Sarup BM, Bhatnagar DP, Maini SC . Glucose 6 phosphate dehydrogenase deficiency in India. J Indian Med Assoc 1972;58:196.

    CAS  PubMed  Google Scholar 

  2. Valaes T, Drummond GS, Kappas A . Control of hyperbilirubinemia in glucose 6 phosphate dehydrogenase deficient newborns using an inhibitor of bilirubin production, Sn-Mesoporphyrin. Pediatrics 1998;101: http://www.pediatrics.org/cgi/content/full/105/5/el.

  3. Kaplan M, Muraca M, Hammerman C, et al. Bilirubin conjugation reflected by conjugated bilirubin fractions in glucose 6 phosphate dehydrogenase deficient neonates — a determining factor in the pathogenesis of hyperbilirubinemia. Pediatrics 1998;102: http://www.pediatrics.org/egi/content/full/102/3/e37.

  4. Meloni T, Costa S, Cuuntilo S . Haptoglobin, hemopexin, hemoglobin and haematocrit in newborns with erythrocytes glucose 6 phosphate dehydrogenase deficiency. Acta Hematol 1975;54:284–288.

    Article  CAS  Google Scholar 

  5. Valaes T, Karaklis A, Stavrakakis D, Bavela-Stavrakakis K, Perakis A, Doxiadis SA . Incidence and mechanism of neonatal jaundice retated to G6PD deficiency. Pediatr Res 1969;3:448–458.

    Article  CAS  Google Scholar 

  6. Kaplan M, Buetller E, Vreman HJ, et al. Neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase deficient heterozygotes. Pediatr 1999;104:68–74.

    Article  CAS  Google Scholar 

  7. Meloni T, Cagnazzo G, Dore A, Cuuntillo S . Phenobarbital for prevention of hyperbilirubinemia in glucose-6-phosphate dehydrogenase deficient newborn infants. J Pediatr 1973;82:1048.

    Article  CAS  Google Scholar 

  8. Meloni T, Dore A, Cuuntilo S . The effect of phenobarbitone in the hyperbilirubinemia of neonates with deficiency of glucose-6-phosphate dehydrogenase of the erythrocytes. Helv Pediatr Acta 1972;274:197 [German].

    Google Scholar 

  9. Gall JC, Brewer GJ, Dern RJ . Studies of glucose-6-phosphate dehydrogenase activity of individual erythrocytes: the methemoglobin elution test for identification of female heterozygotes for G6PD deficiency. Am J Hum Genet. 1965;17:359.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Valaes TN, Harvey-Wilkes K . Pharmacologic approaches to the prevention and treatment of neonatal hyperbilirubinemia. Clin Perinatol 1990;17:245–273.

    Article  CAS  Google Scholar 

  11. National Neonatology Forum. The National Neonatal–Perinatal Database, India. Report for the Year 2000; p. 39.

  12. Cockington RA . A guide to the use of phototherapy in the management of neonatal hyperbilirubinemia. J Pediatr 1979;95:281–285.

    Article  CAS  Google Scholar 

  13. American Academy of Pediatrics: Practice parameter: Management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994;94:558–565.

  14. Bhutani VK, Johnson L, Sivieri EM . Predictive ability of a pre-discharge hour specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near term newborns. Pediatrics 1999;103:6–14.

    Article  CAS  Google Scholar 

  15. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E . Gilbert syndrome and glucose-6-phosphate deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci 1997;94:12128–12132.

    Article  CAS  Google Scholar 

  16. Iolascon A, Faienza MF, Perrotta S, Meloni GF, Ruggiu G, del Giudice EM . Gilbert's syndrome and jaundice in glucose-6-phosphate dehydrogenase deficient neonates. Haematologica 1999;84:99–102.

    CAS  Google Scholar 

  17. Beutler E . G6PD deficiency. Blood 1994;84:3613–3636.

    CAS  Google Scholar 

  18. Mohanty D, Mukherjee MB, Colah RB . Glucose-6-phosphate dehydrogenase deficiency in India. Indian J Pediatr 2004;71:525–529.

    Article  Google Scholar 

  19. Kaplan M, Algur N, Hammerman C . Onset of jaundice in glucose 6 phosphate dehydrogenase deficient neonates. Pediatrics 2001;108:956–959.

    Article  CAS  Google Scholar 

  20. Kumar R, Narang A, Kumar P, Garewal G . Study of postnatal phenobarbitone prophylaxis for neonatal jaundice in babies with birth weight 1000–1499 grams. Indian Pediatr 2002;39:945–951.

    PubMed  Google Scholar 

  21. Cuuntilo S, Meloni T, Dore A . Effect of orotic acid upon serum bilirubin in newborn infants with erythrocyte G6PD deficiency. Acta Paediatr Scand 1974;63:143–146.

    Article  Google Scholar 

  22. Kappas A, Drummond GS, Valaes T . A single dose of Sn-Mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase deficient newborns. Pediatrics 2001;108:25–30.

    Article  CAS  Google Scholar 

  23. Meloni T, Forteleoni G, Dore A, Cutillo S . Neonatal hyperbilirubinemia in heterozygous glucose-6-phosphate dehydrogenase deficient females. Br J Haematol 1983;53:241–246.

    Article  CAS  Google Scholar 

  24. Weng YH, Chou YH, Lien RI . Hyperbilirubinemia in healthy neonates with glucose-6-phosphate dehydrogenase deficiency. Early Hum Dev 2003;71:129–136.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neonatology, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India

    Srinivas Murki, Sourabh Dutta MD & Anil Narang MD

  2. Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

    Urmi Sarkar MSc & Gurjeevan Garewal MD

Authors
  1. Srinivas Murki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sourabh Dutta MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anil Narang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Urmi Sarkar MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gurjeevan Garewal MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Sources of financial assistance: None.

Conflict of interest: None.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murki, S., Dutta, S., Narang, A. et al. A Randomized, Triple-Blind, Placebo-Controlled Trial of Prophylactic Oral Phenobarbital to Reduce the Need for Phototherapy in G6PD-Deficient Neonates. J Perinatol 25, 325–330 (2005). https://doi.org/10.1038/sj.jp.7211258

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211258

This article is cited by

Search

Advanced search

Quick links